tiprankstipranks
Trending News
More News >

Linical Co., Ltd. Reports Financial Downturn with Optimistic Forecast for 2026

Story Highlights
Linical Co., Ltd. Reports Financial Downturn with Optimistic Forecast for 2026

Don’t Miss TipRanks’ Half-Year Sale

Linical Co., Ltd. ( (JP:2183) ) has provided an update.

Linical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ending March 31, 2025, with net sales dropping by 15.2% and a net loss of ¥539 million. Despite the downturn, the company forecasts a recovery in the next fiscal year with an expected 7.3% increase in net sales and a return to profitability.

More about Linical Co., Ltd.

Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the clinical research industry. It focuses on providing services related to drug development and clinical trials, catering to the pharmaceutical and biotechnology sectors.

Average Trading Volume: 50,056

Technical Sentiment Signal: Sell

Current Market Cap: Yen6.71B

See more data about 2183 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1